Monas Tablet 5mg

INDICATION

Monas in indicated for the prophylaxis and chronic treatment of Asthma & for the symptomatic relief of Allergic Rhinitis.

DOSAGE AND ADMINISTRATION

AgeDose6 months– 6 years4 mg/day, in the evening6 years– 15 years5 mg/day, in the evening15 years and older10 mg/day, in the

evening

COMPOSITION

Monas ® 10: Each film coated tablet contains Montelukast Sodium USP equivalent to 10 mg Montelukast.

Monas ® 5 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ® 4 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.

Monas ® 5: Each Chewable tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ® 4: Each Chewable tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.

VIEW PRESCRIBING DETAILS [https://www.acmeglobal.com/wp-content/uploads/2021/01/monas-prescribing-description.pdf]